The Increasing Stress Levels Are Fueling The Growth Of The Market Due To Hormonal Disruption And Decreasing Sperm Quality Is Supporting Development Across The Male Infertility Market

Global Male Infertility Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Male Infertility Market By 2030?

The male infertility market has experienced substantial growth in recent years. It is forecast to grow from $4.33 billion in 2025 to $4.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.6%. The historical growth of this market can be attributed to several factors including declining sperm quality globally, an increased prevalence of lifestyle-related infertility, the expansion of fertility clinics, growing acceptance of ART procedures, and advancements in semen analysis techniques.

The male infertility market size is projected to experience robust expansion in the coming years. It is expected to reach $5.76 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is driven by factors such as increasing infertility rates stemming from environmental influences, a rising demand for IVF and ICSI procedures, advancements in fertility diagnostic technologies, heightened awareness of male reproductive health, and broadened access to fertility treatments in developing markets. Significant trends for the forecast period encompass a greater adoption of assisted reproductive technologies, the increasing utilization of advanced sperm diagnostic tests, a growing emphasis on hormonal and targeted drug therapies, the expansion of microsurgical treatments for male infertility, and improved awareness leading to earlier diagnosis of male infertility.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp

What Core Drivers Are Transforming The Male Infertility Market?

Increasing stress levels are anticipated to boost the expansion of the male infertility market in the coming years. Stress refers to the degree of emotional, physical, or mental strain encountered due to demanding circumstances or pressures. The escalation in stress levels originates from growing work demands, where constant pressure and elevated expectations lead to exhaustion and negatively affect mental well-being and work-life equilibrium. High stress can disrupt hormone balance, reduce sperm quality, and hinder sexual function, thereby contributing to male infertility. Persistent stress interferes with cortisol and testosterone levels, fostering an increase in infertility instances. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization of psychologists, 43% of adults in the US felt more anxious in 2024, compared to 37% in 2023 and 32% in 2022, indicating a consistent increase in anxiety levels. Consequently, the rise in stress levels is propelling the growth of the male infertility market.

Which Segment Divisions Form The Structure Of The Male Infertility Market?

The male infertility market covered in this report is segmented –

1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology

2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types

3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies

4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users

Subsegments:

1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists

2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures

3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm

What Trends Are Shaping The Male Infertility Market Structure?

Major companies in the male infertility market are focusing on strategic partnership approaches to improve access to advanced fertility treatments across global markets. Strategic partnerships involve collaborations between organizations that combine resources and expertise to achieve shared objectives, helping to drive innovation, broaden market presence, and enhance research and development efforts. For instance, in June 2024, Ferring Pharmaceuticals, a Switzerland-based pharmaceutical company, collaborated with Posterity Health, a US-based male fertility clinic, to launch a male fertility program on Ferring’s Fertility Out Loud platform to educate men about their fertility. This initiative provides men with a confidential online assessment and educational resources developed by reproductive urologists, aimed at helping them understand their fertility status and reducing the stigma around male infertility, which contributes to up to 50% of infertility cases. The program aims to empower men to take early action, potentially improving a couple’s path to parenthood by addressing male fertility issues sooner and more conveniently through digital tools and telehealth.

Which Organizations Are Operating Within The Male Infertility Market?

Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics

Access The Complete Male Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report

Which Region Contributes The Most To The Male Infertility Market?

North America was the largest region in the male infertility market in 2025. The regions covered in the male infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Male Infertility Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp

Browse Through More Reports Similar to the Global Male Infertility Market 2026, By The Business Research Company

Male Fertility Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report

Infertility Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Fertility Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model